Prof. Dr. med. Oliver Schnell

Lehrstuhl für Neurochirurgie

ALDH1A1 is a marker of astrocytic differentiation during brain development and correlates with better survival in glioblastoma patients (2012) Alexandra Adam S, Schnell O, Pöschl J, Eigenbrod S, Kretzschmar HA, Tonn JC, Schüller U Journal article Re-irradiation in recurrent malignant glioma: Prognostic value of [ 18F]FET-PET (2012) Niyazi M, Jansen N, Ganswindt U, Schwarz SB, Geisler J, Schnell O, Büsing K, et al. Journal article Molecular markers in low-grade gliomas: Predictive or prognostic? (2011) Hartmann C, Hentschel B, Tatagiba M, Schramm J, Schnell O, Seidel C, Stein R, et al. Journal article Intraoperative computed tomography. (2011) Tonn JC, Schichor C, Schnell O, Zausinger S, Uhl E, Morhard D, Reiser M Journal article FET-PET for malignant glioma treatment planning (2011) Niyazi M, Geisler J, Siefert A, Schwarz SB, Ganswindt U, Garny S, Schnell O, et al. Journal article Presence of pluripotent CD133+ cells correlates with malignancy of gliomas (2010) Thon N, Damianoff K, Hegermann J, Grau S, Krebs B, Schnell O, Tonn JC, Goldbrunner R Journal article Unmet medical needs in glioblastoma management and optimal sequencing of the emerging treatment options (2010) Schnell O, Tonn JC Journal article, Review article 5-aminolevulinic acid-induced protoporphyrin IX levels in tissue of human malignant brain tumors (2010) Johansson A, Palte G, Schnell O, Tonn JC, Herms J, Stepp H Journal article Protoporphyrin IX for photodynamic therapy of brain tumours (2010) Johansson A, Kreth FW, Ardeshiri A, Stummer W, Schnell O, Herms J, Palte G, et al. Conference contribution Imaging of integrin αvβ3 expression in patients with malignant glioma by [18F] Galacto-RGD positron emission tomography (2009) Schnell O, Krebs B, Carlsen J, Miederer I, Goetz C, Goldbrunner RH, Wester HJ, et al. Journal article